Ensuring safety and well-being at Eyecos: Psychological follow-up of our patients

At Eyecos, we take pride in our journey since 2012, leading the way in eye color change with safe and effective technology in the sector. To ensure the suitability of our treatments, we conduct thorough pre-checks, including psychological evaluations, to rule out any possible contraindications. In July 2023, we conducted a psychological study that yielded significant results, and in February 2024, we conducted a follow-up to validate these data.

Our sample, consisting of patients aged 18 to 72, with an average age of 37, showed an increase in the upper age group, raising the average age by one point from the previous study.

When compared to the previous study, we observed that the majority of patients showed no signs of psychological issues, which is encouraging and consistent with previous findings.

We maintain diagnostic categories such as “Anxiety-Stress-Depression,” “Body Dysmorphic Disorder,” “Normal,” and “Obsessive-Paranoid.” Predominantly, patients exhibited a “normal” psychological state, followed by “Obsessive-Paranoid” and “Body Dysmorphic Disorder,” with a decrease in the number of the latter.

Regarding motivations for treatment, the majority sought aesthetic changes, although a smaller number also considered health reasons.

The history of previous surgeries revealed an increase in patients with no prior experience, with a trend towards fewer surgeries performed. We observed a possible correlation with the body dysmorphic profile in cases of multiple interventions.

In the analyzed sample, a wide range of behaviors related to cosmetic treatments was observed. Most clinic patients did not undergo any treatment except for eye color change, which may indicate that the study group does not show a high propensity for such procedures. However, the number of individuals who had undergone one or two previous treatments increased.

Regarding the use of cosmetic medications, the majority did not use them, with very few patients mentioning regular use. Although a case of excessive consumption was recorded, it was uncommon, suggesting that patients typically do not resort to this type of medication.

The majority of patients did not report experiencing significant psychological crises, although a small number mentioned having had one or two crises, with no clear correlation established with cosmetic treatments.

Regarding psychological treatments, most patients continued to receive none, although it was noted that some patients diagnosed with “Anxiety-Stress-Depression” were undergoing pharmacological treatment. Additionally, it was observed that patients diagnosed as “normal” were the ones consuming this type of medication the most.

It is important to mention that only a small number of patients had family histories of mental disorders, suggesting that most participants come from families without such a history.

In conclusion, the results of our psychological studies and data analysis support a safe and effective protocol at Eyecos to initiate a permanent eye color change. Most of our patients show a favorable psychological disposition and a low incidence of mental health problems associated with the procedures. Additionally, we observe a trend towards a reduction in diagnoses of body dysmorphic disorder, while the proportion of patients with a “normal” psychological state increases. These findings suggest that our procedures not only satisfy our patients aesthetically but may also have a positive impact on their psychological well-being.

It is essential to continue monitoring and adapting our protocols to ensure the mental and emotional health of our clients at all times. Patients demonstrate a thoughtful attitude in seeking a solid knowledge base before making decisions related to their treatment, which is fundamental to us at Eyecos.

These results validate Eyecos’ ethical philosophy: we do not promote impulsive or thoughtless decisions and provide all necessary documentation with total transparency, offering direct communication with the treatment specialist of the NewEyes laser, Dr. Grimaldos. We are committed to provide a careful and responsible approach to ensure that our patients make informed decisions and have the necessary support throughout their treatment process.


Thanks for sending the message.

Clínica Eyecos
Telf: +34 938 10 22 50
Calle Tuset 23-25, 08006 Barcelona
Abrir chat
Scan the code
¿En qué podemos ayudarte?